Targeted Expression of Retinoschisin by Retinal Bipolar Cells in XLRS Promotes Resolution of Retinoschisis Cysts Sans RS1 From Photoreceptors
Camasamudram Vijayasarathy, Yong Zeng, Dario Marangoni, Lijin Dong, Zhuo-Hua Pan, Elizabeth M Simpson, Robert N Fariss, Paul A Sieving, Camasamudram Vijayasarathy, Yong Zeng, Dario Marangoni, Lijin Dong, Zhuo-Hua Pan, Elizabeth M Simpson, Robert N Fariss, Paul A Sieving
Abstract
Purpose: Loss of retinoschisin (RS1) function underlies X-linked retinoschisis (XLRS) pathology. In the retina, both photoreceptor inner segments and bipolar cells express RS1. However, the loss of RS1 function causes schisis primarily in the inner retina. To understand these cell type-specific phenotypes, we decoupled RS1 effects in bipolar cells from that in photoreceptors.
Methods: Bipolar cell transgene RS1 expression was achieved using two inner retina-specific promoters: (1) a minimal promoter engineered from glutamate receptor, metabotropic glutamate receptor 6 gene (mini-mGluR6/ Grm6) and (2) MiniPromoter (Ple155). Adeno-associated virus vectors encoding RS1 gene under either the mini-mGluR6 or Ple-155 promoter were delivered to the XLRS mouse retina through intravitreal or subretinal injection on postnatal day 14. Retinal structure and function were assessed 5 weeks later: immunohistochemistry for morphological characterization, optical coherence tomography and electroretinography (ERG) for structural and functional evaluation.
Results: Immunohistochemical analysis of RS1expression showed that expression with the MiniPromoter (Ple155) was heavily enriched in bipolar cells. Despite variations in vector penetrance and gene transfer efficiency across the injected retinas, those retinal areas with robust bipolar cell RS1 expression showed tightly packed bipolar cells with fewer cavities and marked improvement in inner retinal structure and synaptic function as judged by optical coherence tomography and electroretinography, respectively.
Conclusions: These results demonstrate that RS1 gene expression primarily in bipolar cells of the XLRS mouse retina, independent of photoreceptor expression, can ameliorate retinoschisis structural pathology and provide further evidence of RS1 role in cell adhesion.
Trial registration: ClinicalTrials.gov NCT02317887.
Conflict of interest statement
Disclosure: C. Vijayasarathy, None; Y. Zeng, None; D. Marangoni, None; L. Dong, None; Z.-H. Pan, co-inventor of the improved mGluR6 promoter; E.M. Simpson, None; R.N. Fariss, None; P.A. Sieving, co-inventor of the AAV8-RS1 construct and participates in the NIH XLRS gene therapy trial (ClinicalTrials.Gov NCT02317887); Co-Founder of VegaVect Therapeutics, Inc. with intent to conduct work in the XLRS clinical space
Figures
References
- Sauer CG, Gehrig A, Warneke-Wittstock R, et al. .. Positional cloning of the gene associated with X-linked juvenile retinoschisis. Nat Genet. 1997; 17(2): 164–170.
- Gehrig AE, Warneke-Wittstock R, Sauer CG, Weber BH.. Isolation and characterization of the murine X-linked juvenile retinoschisis (Rs1h) gene. Mamm Genome. 1999; 10(3): 303–307.
- Cukras C, Wiley HE, Jeffrey BG, et al. .. Retinal AAV8-RS1 gene therapy for X-linked retinoschisis: initial findings from a phase I/IIa trial by intravitreal delivery. Mol Ther. 2018; 26(9): 2282–2294.
- Mishra A, Vijayasarathy C, Cukras CA, et al. .. Immune function in X-linked retinoschisis subjects in an AAV8-RS1 phase I/IIa gene therapy trial. Mol Ther. 2021; 29: 2030–2040.
- Pennesi ME, Yang P, Birch DG, et al. .. Intravitreal delivery of rAAV2tYF-CB-hRS1 vector for gene augmentation therapy in patients with X-linked retinoschisis: 1-year clinical results. Ophthalmol Retina. 2022 Jun 30, S2468-6530(22)00320-7. Online ahead of print, doi:10.1016/j.oret.2022.06.013.
- Vijayasarathy C, Sardar Pasha SPB, Sieving PA. Of men and mice: human X-linked retinoschisis and fidelity in mouse modeling. Prog Retin Eye Res. 2022; 87: 100999.
- Ambrosio L, Hansen RM, Kimia R, Fulton AB.. Retinal function in X-linked juvenile retinoschisis. Invest Ophthalmol Vis Sci. 2019; 60(14): 4872–4881.
- Rao P, Dedania VS, Drenser KA.. Congenital X-linked retinoschisis: an updated clinical review. Asia Pac J Ophthalmol (Phila). 2018; 7(3): 169–175.
- Wood EH, Lertjirachai I, Ghiam BK, et al. .. The natural history of congenital X-linked retinoschisis and conversion between phenotypes over time. Ophthalmol Retina. 2019; 3(1): 77–82.
- Molday RS, Kellner U, Weber BH.. X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms. Prog Retin Eye Res. 2012; 31(3): 195–212.
- Sikkink SK, Biswas S, Parry NR, Stanga PE, Trump D.. X-linked retinoschisis: an update. J Med Genet. 2007; 44(4): 225–232.
- Takada Y, Fariss RN, Muller M, Bush RA, Rushing EJ, Sieving PA.. Retinoschisin expression and localization in rodent and human pineal and consequences of mouse RS1 gene knockout. Mol Vis. 2006; 12: 1108–1116.
- Molday LL, Hicks D, Sauer CG, Weber BH, Molday RS.. Expression of X-linked retinoschisis protein RS1 in photoreceptor and bipolar cells. Invest Ophthalmol Vis Sci. 2001; 42(3): 816–825.
- Grayson C, Reid SN, Ellis JA, et al. .. Retinoschisin, the X-linked retinoschisis protein, is a secreted photoreceptor protein, and is expressed and released by Weri-Rb1 cells. Hum Mol Genet. 2000; 9(12): 1873–1879.
- Vijayasarathy C, Takada Y, Zeng Y, Bush RA, Sieving PA.. Retinoschisin is a peripheral membrane protein with affinity for anionic phospholipids and affected by divalent cations. Invest Ophthalmol Vis Sci. 2007; 48(3): 991–1000.
- Kiedzierska A, Smietana K, Czepczynska H, Otlewski J.. Structural similarities and functional diversity of eukaryotic discoidin-like domains. Biochim Biophys Acta. 2007; 1774(9): 1069–1078.
- Weber BH, Schrewe H, Molday LL, et al. .. Inactivation of the murine X-linked juvenile retinoschisis gene, Rs1h, suggests a role of retinoschisin in retinal cell layer organization and synaptic structure. Proc Natl Acad Sci USA. 2002; 99(9): 6222–6227.
- Tolun G, Vijayasarathy C, Huang R, et al. .. Paired octamer rings of retinoschisin suggest a junctional model for cell-cell adhesion in the retina. Proc Natl Acad Sci USA. 2016; 113(19): 5287–5292.
- Ramsay EP, Collins RF, Owens TW, et al. .. Structural analysis of X-linked retinoschisis mutations reveals distinct classes which differentially effect retinoschisin function. Hum Mol Genet. 2016; 25(24): 5311–5320.
- Bush M, Setiaputra D, Yip CK, Molday RS.. Cog-wheel octameric structure of RS1, the discoidin domain containing retinal protein associated with X-linked retinoschisis. PLoS One. 2016; 11(1): e0147653.
- Ou J, Vijayasarathy C, Ziccardi L, et al. .. Synaptic pathology and therapeutic repair in adult retinoschisis mouse by AAV-RS1 transfer. J Clin Invest. 2015; 125(7): 2891–2903.
- Ling KP, Mangalesh S, Tran-Viet D, Gunther R, Toth CA, Vajzovic L.. Handheld spectral domain optical coherence tomography findings of X-linked retinoschisis in early childhood. Retina. 2020; 40(10): 1996–2003.
- Tsang SH, Vaclavik V, Bird AC, Robson AG, Holder GE.. Novel phenotypic and genotypic findings in X-linked retinoschisis. Arch Ophthalmol. 2007; 125(2): 259–267.
- Gehrig A, Janssen A, Horling F, Grimm C, Weber BH.. The role of caspases in photoreceptor cell death of the retinoschisin-deficient mouse. Cytogenet Genome Res. 2006; 115(1): 35–44.
- Lu Q, Ganjawala TH, Ivanova E, Cheng JG, Troilo D, Pan ZH.. AAV-mediated transduction and targeting of retinal bipolar cells with improved mGluR6 promoters in rodents and primates. Gene Ther. 2016; 23(8–9): 680–689.
- de Leeuw CN, Dyka FM, Boye SL, et al. .. Targeted CNS delivery using human minipromoters and demonstrated compatibility with adeno-associated viral vectors. Mol Ther Methods Clin Dev. 2014; 1: 5.
- Scalabrino ML, Boye SL, Fransen KM, et al. .. Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness. Hum Mol Genet. 2015; 24(21): 6229–6239.
- de Leeuw CN, Korecki AJ, Berry GE, et al. .. rAAV-compatible MiniPromoters for restricted expression in the brain and eye. Mol Brain. 2016; 9(1): 52.
- Korecki AJ, Cueva-Vargas JL, Fornes O, et al. .. Human MiniPromoters for ocular-rAAV expression in ON bipolar, cone, corneal, endothelial, Muller glial, and PAX6 cells. Gene Ther. 2021; 28(6): 351–372.
- Takada Y, Fariss RN, Tanikawa A, et al. .. A retinal neuronal developmental wave of retinoschisin expression begins in ganglion cells during layer formation. Invest Ophthalmol Vis Sci. 2004; 45(9): 3302–3312.
- Takada Y, Vijayasarathy C, Zeng Y, Kjellstrom S, Bush RA, Sieving PA.. Synaptic pathology in retinoschisis knockout (Rs1-/y) mouse retina and modification by rAAV-Rs1 gene delivery. Invest Ophthalmol Vis Sci. 2008; 49(8): 3677–3686.
- Kjellstrom S, Bush RA, Zeng Y, Takada Y, Sieving PA.. Retinoschisin gene therapy and natural history in the Rs1h-KO mouse: long-term rescue from retinal degeneration. Invest Ophthalmol Vis Sci. 2007; 48(8): 3837–3845.
- Zeng Y, Takada Y, Kjellstrom S, et al. .. RS-1 gene delivery to an adult Rs1h knockout mouse model restores ERG b-wave with reversal of the electronegative waveform of X-linked retinoschisis. Invest Ophthalmol Vis Sci. 2004; 45(9): 3279–3285.
- Ueda Y, Iwakabe H, Masu M, Suzuki M, Nakanishi S.. The mGluR6 5' upstream transgene sequence directs a cell-specific and developmentally regulated expression in retinal rod and ON-type cone bipolar cells. J Neurosci. 1997; 17(9): 3014–3023.
- Kim DS, Matsuda T, Cepko CL.. A core paired-type and POU homeodomain-containing transcription factor program drives retinal bipolar cell gene expression. J Neurosci. 2008; 28(31): 7748–7764.
- Hickmott JW, Chen CY, Arenillas DJ, et al. .. PAX6 MiniPromoters drive restricted expression from rAAV in the adult mouse retina. Mol Ther Methods Clin Dev. 2016; 3: 16051.
- Simpson EM, Korecki AJ, Fornes O, et al. .. New MiniPromoter Ple345 (NEFL) drives strong and specific expression in retinal ganglion cells of mouse and primate retina. Hum Gene Ther. 2019; 30(3): 257–272.
- Barski JJ, Dethleffsen K, Meyer M.. Cre recombinase expression in cerebellar Purkinje cells. Genesis. 2000; 28(3-4): 93–98.
- Vandaele S, Nordquist DT, Feddersen RM, Tretjakoff I, Peterson AC, Orr HT.. Purkinje cell protein-2 regulatory regions and transgene expression in cerebellar compartments. Genes Dev. 1991; 5(7): 1136–1148.
- Zhang XM, Chen BY, Ng AH, et al. .. Transgenic mice expressing Cre-recombinase specifically in retinal rod bipolar neurons. Invest Ophthalmol Vis Sci. 2005; 46(10): 3515–3520.
- Zeng Y, Petralia RS, Vijayasarathy C, et al. .. Retinal structure and gene therapy outcome in retinoschisin-deficient mice assessed by spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2016; 57(9): OCT277–OCT287.
- Molday LL, Wu WW, Molday RS.. Retinoschisin (RS1), the protein encoded by the X-linked retinoschisis gene, is anchored to the surface of retinal photoreceptor and bipolar cells through its interactions with a Na/K ATPase-SARM1 complex. J Biol Chem. 2007; 282(45): 32792–32801.
- Plossl K, Royer M, Bernklau S, et al. .. Retinoschisin is linked to retinal Na/K-ATPase signaling and localization. Mol Biol Cell. 2017; 28(16): 2178–2189.
- Fernandez-Sanchez L, Lax P, Campello L, Pinilla I, Cuenca N.. Astrocytes and Muller cell alterations during retinal degeneration in a transgenic rat model of retinitis pigmentosa. Front Cell Neurosci. 2015; 9: 484.
- Reichenbach A, Bringmann A.. New functions of Muller cells. Glia. 2013; 61(5): 651–678.
- Bush RA, Zeng Y, Colosi P, et al. .. Preclinical dose-escalation study of intravitreal AAV-rs1 gene therapy in a mouse model of X-linked retinoschisis: dose-dependent expression and improved retinal structure and function. Hum Gene Ther. 2016; 27(5): 376–389.
- West ER, Cepko CL.. Development and diversification of bipolar interneurons in the mammalian retina. Dev Biol. 2022; 481: 30–42.
- Kim DS, Ross SE, Trimarchi JM, Aach J, Greenberg ME, Cepko CL.. Identification of molecular markers of bipolar cells in the murine retina. J Comp Neurol. 2008; 507(5): 1795–1810.
- Euler T, Haverkamp S, Schubert T, Baden T.. Retinal bipolar cells: elementary building blocks of vision. Nat Rev Neurosci. 2014; 15(8): 507–519.
- Reid SN, Farber DB.. Glial transcytosis of a photoreceptor-secreted signaling protein, retinoschisin. Glia. 2005; 49(3): 397–406.
- Eleftheriou CG, Corona C, Khattak S, et al. .. Retinoschisin deficiency induces persistent aberrant waves of activity affecting neuroglial signaling in the retina. J Neurosci. 2022; 29(36): 6983–7000. JN-RM-2128-21, doi:10.1523/JNEUROSCI.2128-21.2022.
- Min SH, Molday LL, Seeliger MW, et al. .. Prolonged recovery of retinal structure/function after gene therapy in an Rs1h-deficient mouse model of x-linked juvenile retinoschisis. Mol Ther. 2005; 12(4): 644–651.
- Byrne LC, Ozturk BE, Lee T, et al. .. Retinoschisin gene therapy in photoreceptors, Muller glia or all retinal cells in the Rs1h-/- mouse. Gene Ther. 2014; 21(6): 585–592.
- Gehrig A, Langmann T, Horling F, et al. .. Genome-wide expression profiling of the retinoschisin-deficient retina in early postnatal mouse development. Invest Ophthalmol Vis Sci. 2007; 48(2): 891–900.
- Vijayasarathy C, Zeng Y, Brooks M, Fariss RN, Sieving PA.. Genetic rescue of X-linked retinoschisis mouse (Rs1-/y) retina induces quiescence of the retinal microglial inflammatory state following AAV8-RS1 gene transfer and identifies gene networks underlying retinal recovery. Hum Gene Ther. 2020; 32(13–14): 667–681.
- Zhao L, Zabel MK, Wang X, et al. .. Microglial phagocytosis of living photoreceptors contributes to inherited retinal degeneration. EMBO Mol Med. 2015; 7(9): 1179–1197.
- Bowles K, Cukras C, Turriff A, et al. .. X-linked retinoschisis: RS1 mutation severity and age affect the ERG phenotype in a cohort of 68 affected male subjects. Invest Ophthalmol Vis Sci. 2011; 52(12): 9250–9256.
- Friedrich U, Stohr H, Hilfinger D, et al. .. The Na/K-ATPase is obligatory for membrane anchorage of retinoschisin, the protein involved in the pathogenesis of X-linked juvenile retinoschisis. Hum Mol Genet. 2011; 20(6): 1132–1142.
- Plossl K, Straub K, Schmid V, et al. .. Identification of the retinoschisin-binding site on the retinal Na/K-ATPase. PLoS One. 2019; 14(5): e0216320.
- Schmid V, Wurzel A, Wetzel CH, et al. .. Retinoschisin and novel Na/K-ATPase interaction partners Kv2.1 and Kv8.2 define a growing protein complex at the inner segments of mammalian photoreceptors. Cell Mol Life Sci. 2022; 79(8): 448, 10.1007/s00018-022-04409-9.
Source: PubMed